Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib

Breast cancer is a heterogeneous disease. Understanding the tumor subtypes can help identify the best option of treatment. Mathematical modeling of tumor growth is a useful tool to understand the observed clinical phenomena. This work is based on a previously published mathematical model of breast c...

Full description

Saved in:
Bibliographic Details
Published inAIMS mathematics Vol. 5; no. 4; pp. 3446 - 3455
Main Author Wei, Hsiu-Chuan
Format Journal Article
LanguageEnglish
Published AIMS Press 01.01.2020
Subjects
breast cancer
cancer treatment
mathematical modeling
mathematical simulation
mcf-7 cell line
Online AccessGet full text

Cover

More Information
Summary:Breast cancer is a heterogeneous disease. Understanding the tumor subtypes can help identify the best option of treatment. Mathematical modeling of tumor growth is a useful tool to understand the observed clinical phenomena. This work is based on a previously published mathematical model of breast cancer in MCF-7 cell line. In this paper, cancer therapy using AZD9496 and palbociclib is incorporated into the mathematical model. Numerical results produced using the mathematical model are compared with those observed in clinical and experimental studies. Numerical simulation shows that monotherapy with AZD9496 can inhibit the growth of a tumor with a restricted tumor size, monotherapy with palbociclib is ineffective, and combination therapy with AZD9496 and palbociclib can produce synergistic effect and control a larger tumor.
ISSN:2473-6988
2473-6988
DOI:10.3934/math.2020223